Rare Disease Trial, Recruiting (NCT04429750)

Rare Disease Trial, Recruiting NCT04429750 Sponsor: University Hospital, Lille Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04429750 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your baby has been diagnosed with CDH (a condition where organs move into the chest through a hole in the diaphragm) before birth
Your baby has no other serious birth defects or chromosomal conditions
Your baby is born at full term (after 36 weeks of pregnancy)
Your baby is not already part of another pregnancy-related clinical trial
Both parents are willing and able to sign a written consent form agreeing to take part

Who may not be able to join:

Your baby is born prematurely, before 37 weeks of pregnancy
Your baby has other serious birth defects or chromosomal conditions
You are expecting twins
Parents who have significant difficulty understanding French may not be able to take part, unless they receive proper help understanding the consent forms — and even if included, some questionnaires and psychology interviews may not be offered depending on their level of French (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Laurent Storme, MD,PhD, University Hospital, Lille

Phone: 03 20 44 61 99

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04429750

Sponsor: University Hospital, Lille

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: 03 20 44 61 99

More information: https://clinicaltrials.gov/study/NCT04429750

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your baby has been diagnosed with CDH (a condition where organs move into the chest through a hole in the diaphragm) before birth
Your baby has no other serious birth defects or chromosomal conditions
Your baby is born at full term (after 36 weeks of pregnancy)
Your baby is not already part of another pregnancy-related clinical trial
Both parents are willing and able to sign a written consent form agreeing to take part

Who may not be able to join:

Your baby is born prematurely, before 37 weeks of pregnancy
Your baby has other serious birth defects or chromosomal conditions
You are expecting twins
Parents who have significant difficulty understanding French may not be able to take part, unless they receive proper help understanding the consent forms — and even if included, some questionnaires and psychology interviews may not be offered depending on their level of French (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Lille

Registry

ClinicalTrials.gov

Start date

8 October 2020

Est. completion

1 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Number of infants with APGAR score < 4 at 1 min or < 7 at 5 min.; APGAR score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov